Drug Approval | August 17, 2023
Glenmark Pharmaceuticals receives sANDA approval for Tacrolimus Ointment, 0.03%
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
The inspection was conducted at its Goa, Vema manufacturing facility
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
The company has secured 506 marketing approvals for its oncology products across 76 countries.
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
Subscribe To Our Newsletter & Stay Updated
